Plasmodium falciparum Drug Resistance Genes pfmdr1 and pfcrt In Vivo Co-Expression During Artemether-Lumefantrine Therapy
Background: Artemisinin-based combination therapies (ACTs) are the global mainstay treatment of uncomplicated Plasmodium falciparum infections. PfMDR1 and PfCRT are two transmembrane transporters, associated with sensitivity to several antimalarials, found in the parasite food vacuole. Herein, we ex...
Saved in:
Main Authors: | M. Silva (Author), M. Malmberg (Author), S. D. Otienoburu (Author), A. Björkman (Author), B. Ngasala (Author), A. Mårtensson (Author), J. P. Gil (Author), M. I. Veiga (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
by: Stephan Ehrhardt, et al.
Published: (2009) -
Open-label trial on efficacy of artemether/lumefantrine against the uncomplicated Plasmodium falciparum malaria in Metema district, Northwestern Ethiopia
by: Wudneh F, et al.
Published: (2016) -
Synergism between Pfcrt and Pfmdr1 genes could account for the slow recovery of chloroquine sensitive Plasmodium falciparum strains in Ghana after chloroquine withdrawal
by: Kwame K. Asare, et al.
Published: (2017) -
In vivo efficacy of artemether–lumefantrine against uncomplicated Plasmodium falciparum malaria in Dembia District, northwest Ethiopia
by: Deressa T, et al.
Published: (2017) -
Prevalence of Plasmodium falciparum chloroquine resistant gene markers, pfcrt-76 and pfmdr1-86, eight years after cessation of chloroquine use in Mwea, Kenya
by: Sabah Ahmed Omar,1 Francis W. Makokha,2,3 Fat'hia Abdo Mohammed,1 Francis T. Kimani,1 Gabriel Magoma3
Published: (2007)